{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:43:28Z","timestamp":1790394208718,"version":"4.1.0"},"reference-count":179,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2016.00153","type":"journal-article","created":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T08:58:04Z","timestamp":1461056284000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":129,"title":["Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants"],"prefix":"10.3389","volume":"10","author":[{"given":"Cristina","family":"Miliano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Serpelloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Rimondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Mereu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Marti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,4,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1007\/s00213-015-3944-8","article-title":"In vivo potency and efficacy of the novel cathinone \u03b1-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats","volume":"232","author":"Aarde","year":"2015","journal-title":"Psychopharmacology (Berl.)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.neuropharm.2013.04.003","article-title":"The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats","volume":"71","author":"Aarde","year":"2013","journal-title":"Neuropharmacology"},{"key":"B3","author":"ACMD (Advisory Council on the Misuse of Drugs)","year":"2009","journal-title":"Review of the ACMD, 2009 - Publications - GOV.UK."},{"key":"B4","author":"ACMD (Advisory Council on the Misuse of Drugs)","year":"2012","journal-title":"Methoxetamine report, 2012 - Publications - GOV.UK"},{"key":"B5","volume-title":"Ketamine: A Review of Use and Harm","author":"ACMD (Advisory Council on the Misuse of Drugs)","year":"2013"},{"key":"B6","author":"ACMD (Advisory Council on the Misuse of Drugs)","year":"2014","journal-title":"IMSD 2014\/ACMD 2014."},{"key":"B7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/jnc.13048","article-title":"3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: \u03b2-ketoamphetamine modulation of neurotoxicity by the dopamine transporter","volume":"133","author":"Anneken","year":"2015","journal-title":"J. Neurochem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/00008877-200509000-00024","article-title":"Behavioral pharmacological properties of a novel cannabinoid 1\u2032,1\u2032-dithiolane delta8-THC analog, AMG-3","volume":"16","author":"Antoniou","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00204-015-1513-x","article-title":"The hallucinogenic world of tryptamines: an updated review","volume":"89","author":"Ara\u00fajo","year":"2015","journal-title":"Arch. Toxicol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1476-5381.2009.00582.x","article-title":"JWH018, a common constituent of \u201cSpice\u201d herbal blends, is a potent and efficacious cannabinoid CB 1 receptor agonist","volume":"160","author":"Atwood","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejphar.2011.01.066","article-title":"CP47,497-C8 and JWH073, commonly found in \u201cSpice\u201d herbal blends, are potent and efficacious CB(1) cannabinoid receptor agonists","volume":"659","author":"Atwood","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.pbb.2008.02.018","article-title":"Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain","volume":"90","author":"Baumann","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2012.11.020","article-title":"Psychoactive \u201cbath salts\u201d: Not so soothing","volume":"698","author":"Baumann","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"734749","DOI":"10.1155\/2014\/734749","article-title":"25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug","volume":"2014","author":"Bersani","year":"2014","journal-title":"Biomed Res. Int."},{"key":"B16","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jemermed.2015.06.053","article-title":"Synthetic cannabinoid abuse in adolescents: a case series","volume":"49","author":"Besli","year":"2015","journal-title":"J. Emerg. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/npp.2008.138","article-title":"Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum","volume":"34","author":"Bossong","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ejphar.2015.10.004","article-title":"Evaluation of the abuse potential of AM281, a new synthetic cannabinoid CB1 receptor antagonist","volume":"766","author":"Botanas","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3109\/03602532.2013.839700","article-title":"The K2\/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products","volume":"46","author":"Brents","year":"2014","journal-title":"Drug Metab. Rev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e21917","DOI":"10.1371\/journal.pone.0021917","article-title":"Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity","volume":"6","author":"Brents","year":"2011","journal-title":"PLoS ONE"},{"key":"B22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/jspn.12057","article-title":"A review of clinical manifestations in adolescent and young adults after use of synthetic cannabinoids","volume":"19","author":"Brewer","year":"2014","journal-title":"J. Spec. Pediatr. Nurs."},{"key":"B24","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/dta.1613","article-title":"Monitoring drug markets in the Internet age and the evolution of drug monitoring systems in Australia","volume":"6","author":"Burns","year":"2014","journal-title":"Drug Test. Anal."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1038\/nprot.2007.441","article-title":"Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation","volume":"2","author":"Carlezon","year":"2007","journal-title":"Nat. Protoc."},{"key":"B26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1615\/CritRevNeurobiol.v13.i3.20","article-title":"Behavioral effects of cannabinoid agents in animals","volume":"13","author":"Chaperon","year":"1999","journal-title":"Crit. Rev. Neurobiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s002130050518","article-title":"Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats","volume":"135","author":"Chaperon","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s002130000481","article-title":"Cannabinoid receptors and reward in the rat: a conditioned place preference study","volume":"151","author":"Cheer","year":"2000","journal-title":"Psychopharmacology (Berl)."},{"key":"B29","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1523\/JNEUROSCI.0529-04.2004","article-title":"Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats","volume":"24","author":"Cheer","year":"2004","journal-title":"J. Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0006-8993(93)90298-2","article-title":"Ventral tegmental microinjection of delta 9-tetrahydrocannabinol enhances ventral tegmental somatodendritic dopamine levels but not forebrain dopamine levels: evidence for local neural action by marijuana's psychoactive ingredient","volume":"621","author":"Chen","year":"1993","journal-title":"Brain Res."},{"key":"B31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0022-3565(25)11216-0","article-title":"Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents","volume":"260","author":"Compton","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.toxlet.2012.03.009","article-title":"Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as \u201cbath salts\u201d or \u201cplant food.\u201d","volume":"211","author":"Coppola","year":"2012","journal-title":"Toxicol. Lett."},{"key":"B33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2174\/157488411796151129","article-title":"Designer drugs on the internet: a phenomenon out-of-control? the emergence ofhallucinogenic drug Bromo-Dragonfly","volume":"6","author":"Corazza","year":"2011","journal-title":"Curr. Clin. Pharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/02791072.2014.944291","article-title":"\u201cSpice,\u201d \u201ckryptonite,\u201d \u201cblack mamba\u201d: an overview of brand names and marketing strategies of novel psychoactive substances on the web","volume":"46","author":"Corazza","year":"2014","journal-title":"J. Psychoactive Drugs"},{"key":"B35","first-page":"355","article-title":"Mephedrone-related fatalities in the United Kingdom: contextual, clinical and practicalissues","author":"Corkery","year":"2012"},{"key":"B36","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/hup.2298","article-title":"MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine; \u201csparkle\u201d; \u201cmindy\u201d) toxicity: a brief overview and update","volume":"28","author":"Corkery","year":"2013","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"B37","author":"Corkery","year":"2014","journal-title":"Drug Related Deaths in the, UK"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s00702-009-0308-8","article-title":"Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter","volume":"116","author":"Cozzi","year":"2009","journal-title":"J. Neural Transm."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1177\/0269881111430733","article-title":"Desoxypipradrol is more potent than cocaine on evoked dopamine efflux in the nucleus accumbens","volume":"26","author":"Davidson","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.pnpbp.2013.08.013","article-title":"The effects of benzofury (5-APB) on the dopamine transporter and 5-HT2-dependent vasoconstriction in the rat","volume":"48","author":"Dawson","year":"2014","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatry"},{"key":"B42","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.neuropharm.2015.08.041","article-title":"Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid","volume":"99","author":"De Luca","year":"2015a","journal-title":"Neuropharmacology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.neuropharm.2011.10.018","article-title":"Cannabinoid facilitation of behavioral and biochemical hedonic taste responses","volume":"63","author":"De Luca","year":"2012","journal-title":"Neuropharmacology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.neuropharm.2015.11.017","article-title":"Native CB1 receptor affinity, intrisic activity and accumbens shell dopamine stimulant properties of third generation spice\/K2 cannabinoids: BB-22, 5F-PB-22, 5F-AKB-48 and STS-135","volume":"105","author":"De Luca","year":"2015b","journal-title":"Neuropharmacology."},{"key":"B45","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s13181-013-0295-x","article-title":"2C or not 2C: phenethylamine designer drug review","volume":"9","author":"Dean","year":"2013","journal-title":"J. Med. Toxicol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.pnpbp.2012.07.011","article-title":"Identifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping Project","volume":"39","author":"Deluca","year":"2012","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatry"},{"key":"B47","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/jat\/bks095","article-title":"Identification and structural elucidation of four cannabimimetic compounds (RCS-4, AM-2201, JWH-203 and JWH-210) in seized products","volume":"37","author":"Denooz","year":"2013","journal-title":"J. Anal. Toxicol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.neuropharm.2004.06.032","article-title":"Dopamine and drug addiction: The nucleus accumbens shell connection","volume":"47","author":"Di Chiara","year":"2004","journal-title":"Neuropharmacology"},{"key":"B49","author":"Drug Policy Department Italian Presidency of the Council of Ministers","year":"2013a","journal-title":"National Action Plan on New Psychoactive Substances"},{"key":"B50","volume-title":"New Psychoactive Substances","author":"Drug Policy Department Italian Presidency of the Council of Ministers","year":"2013b"},{"key":"B51","volume-title":"Annual Report on Drug.","author":"Drug Policy Department Italian Presidency of the Council of Ministers","year":"2014"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/npp.2012.8","article-title":"Dose-related modulation of event-related potentials to novel and target stimuli by intravenous delta9-THC in humans","volume":"37","author":"D'Souza","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"B53","author":"EMCDDA (European Drug Report)","year":"2014","journal-title":"Trends and Developments."},{"key":"B54","author":"EMCDDA","year":"2009a","journal-title":"Annual Report on the State of the Drugs Problem in Europe"},{"key":"B55","volume-title":"Thematic Papers","author":"EMCDDA","year":"2009b"},{"key":"B56","author":"EMCDDA (European Drug Report)","year":"2015a","journal-title":"Trends and Developments"},{"key":"B57","author":"EMCDDA (New psychoactive substances in Europe)","year":"2015b","journal-title":"An Update from the EU Early Warning System"},{"key":"B58","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00213-013-3303-6","article-title":"Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function","volume":"231","author":"Eshleman","year":"2014","journal-title":"Psychopharmacology (Berl.)"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.bcp.2013.04.004","article-title":"Substituted methcathinones differ in transporter and receptor interactions","volume":"85","author":"Eshleman","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.drugalcdep.2011.01.012","article-title":"Synthetic cannabinoid JWH-018 and psychosis: an explorative study","volume":"117","author":"Every-Palmer","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"B61","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bcp.2007.07.018","article-title":"The behavioral pharmacology of hallucinogens","volume":"75","author":"Fantegrossi","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1345\/aph.1Q628","article-title":"Synthetic Cathinones (Bath Salts): legal status and patterns of abuse","volume":"46","author":"Fass","year":"2012","journal-title":"Ann. Pharmacother."},{"issue":"60","key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2011.00060","article-title":"Beyond THC: The new generation of cannabinoid designer drugs","volume":"5","author":"Fattore","year":"2011","journal-title":"Front. Behav. Neurosci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s002130100734","article-title":"Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats","volume":"156","author":"Fattore","year":"2001","journal-title":"Psychopharmacology (Berl)."},{"key":"B65","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1126\/science.1166127","article-title":"NIH Public Access","volume":"Vol. 323","author":"Fontanilla","year":"2010","journal-title":"Science"},{"key":"B66","volume-title":"New Psychoactive Substances \u2013 Evidence Review, Safer Communities Analytical Unit","author":"Fraser","year":"2014"},{"key":"B67","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1097\/FBP.0000000000000093","article-title":"\u03949-Tetrahydrocannabinol-like discriminative stimulus effects of compounds commonly found in K2\/Spice","volume":"25","author":"Gatch","year":"2014","journal-title":"Behav. Pharmacol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/FBP.0000000000000150","article-title":"\u03949-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids found on the gray market","volume":"26","author":"Gatch","year":"2015","journal-title":"Behav. Pharmacol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00213-009-1501-z","article-title":"Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats","volume":"204","author":"Gatch","year":"2009","journal-title":"Psychopharmacology (Berl)."},{"key":"B70","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/FBP.0b013e328364166d","article-title":"Locomotor stimulant and discriminative stimulus effects of \u201cbath salt\u201d cathinones","volume":"24","author":"Gatch","year":"2013","journal-title":"Behav. Pharmacol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.lfs.2013.07.023","article-title":"Bath salts and synthetic cathinones: an emerging designer drug phenomenon","volume":"97","author":"German","year":"2014","journal-title":"Life Sci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0306-4522(96)00428-9","article-title":"Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain","volume":"77","author":"Glass","year":"1997","journal-title":"Neuroscience"},{"key":"B73","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/hup.2323","article-title":"Consumption of new psychoactive substances in a Spanish sample of research chemical users","volume":"28","author":"Gonz\u00e1lez","year":"2013","journal-title":"Hum. Psychopharmacol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nlm.2015.06.008","article-title":"The influence of cannabinoids on learning and memory processes of the dorsal striatum","volume":"125","author":"Goodman","year":"2015","journal-title":"Neurobiol. Learn. Mem."},{"key":"B76","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.drugalcdep.2015.01.022","article-title":"Effects of acute and repeated dosing of the synthetic cannabinoid CP55,940 on intracranial self-stimulation in mice","volume":"150","author":"Grim","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"B77","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1521-0391.2012.00240.x","article-title":"\u201cSpice\u201d and \u201cK2\u201d Herbal Highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans","volume":"21","author":"Gunderson","year":"2012","journal-title":"Am. J. Addict."},{"key":"B79","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0306-4522(91)90202-Y","article-title":"Specificity in the projection patterns of accumbal core and shell in the rat","volume":"41","author":"Heimer","year":"1991","journal-title":"Neuroscience"},{"key":"B80","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3109\/00365513.2013.793817","article-title":"Identification of novel psychoactive drug use in Sweden based on laboratory analysis\u2013initial experiences from the STRIDA project","volume":"73","author":"Helander","year":"2013","journal-title":"Scand. J. Clin. Lab Invest."},{"key":"B81","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.forsciint.2014.02.022","article-title":"Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project","volume":"243","author":"Helander","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"B82","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"J. Neurosci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1360-0443.2012.04078.x","article-title":"Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings","volume":"108","author":"Hermanns-Clausen","year":"2013","journal-title":"Addiction"},{"key":"B84","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/neuro.07.006.2007","article-title":"Endocannabinoid signaling is critical for habit formation","volume":"1","author":"Hil\u00e1rio","year":"2007","journal-title":"Front. Integr. Neurosci."},{"key":"B85","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3238\/arztebl.2014.0139","article-title":"Effects and risks associated with novel psychoactive substances: mislabeling and sale as bath salts, spice, and research chemicals","volume":"111","author":"Hohmann","year":"2014","journal-title":"Dtsch. Arztebl. Int."},{"key":"B86","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.drugalcdep.2014.11.033","article-title":"Monitoring new psychoactive substances (NPS) in The Netherlands: data from the drug market and the Poisons Information Centre","volume":"147","author":"Hondebrink","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1111\/adb.12299","article-title":"The new stimulant designer compound pentedrone exhibits rewarding properties and affects dopaminergic activity","author":"Hwang","year":"2015","journal-title":"Addict. Biol."},{"key":"B88","volume-title":"The 2012 Annual Report of the Drug Recognition Expert Section","author":"IACP (International Association of Chiefs of Police)","year":"2012"},{"key":"B89","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ejphar.2012.12.006","article-title":"Neurochemical profiles of some novel psychoactive substances","volume":"700","author":"Iversen","year":"2013","journal-title":"Eur. J. Pharmacol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.neuropharm.2014.01.015","article-title":"Designer psychostimulants: pharmacology and differences","volume":"87","author":"Iversen","year":"2014","journal-title":"Neuropharmacology"},{"key":"B91","author":"Johnston","year":"2013","journal-title":"Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings"},{"key":"B92","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s00213-003-1693-6","article-title":"The opioid antagonist naltrexone reduces the reinforcing effects of Delta 9 tetrahydrocannabinol (THC) in squirrel monkeys","volume":"173","author":"Justinova","year":"2004","journal-title":"Psychopharmacology (Berl)."},{"key":"B93","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2174\/1570159X13666141210224137","article-title":"Synthetic cathinones: a new public health problem","volume":"13","author":"Karila","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/dta.313","article-title":"Cathinone derivatives: A review of their chemistry, pharmacology and toxicology","volume":"3","author":"Kelly","year":"2011","journal-title":"Drug Test. Anal."},{"key":"B97","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1177\/0897190014544814","article-title":"Toxicology and management of novel psychoactive drugs","volume":"28","author":"Kersten","year":"2015","journal-title":"J. Pharm. Pract."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1007\/s11606-014-2802-4","article-title":"Emergence of New Classes of Recreational Drugs\u2014Synthetic Cannabinoids and Cathinones","volume":"29","author":"Khullar","year":"2014","journal-title":"J. Gen. Intern. Med."},{"key":"B99","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/dta.1584","article-title":"Changes in the prevalence of new psychoactive substances before and after the introduction of the generic scheduling of synthetic cannabinoids in Japan","volume":"6","author":"Kikura-Hanajiri","year":"2014","journal-title":"Drug Test. Anal."},{"key":"B100","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/npp.2009.110","article-title":"Neurocircuitry of addiction","volume":"35","author":"Koob","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"B101","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1007\/s00216-013-7574-x","article-title":"LC-QTOF-MS as a superior strategy to immunoassay for the comprehensive analysis of synthetic cannabinoids in urine","volume":"406","author":"Kronstrand","year":"2014","journal-title":"Anal. Bioanal. Chem."},{"key":"B102","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1124\/jpet.112.197780","article-title":"Dissociable effects of the cannabinoid receptor agonists \u03949-tetrahydrocannabinol and CP55940 on pain-stimulated versus pain-depressed behavior in rats","volume":"343","author":"Kwilasz","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B103","first-page":"3270","article-title":"NBOMe : new potent hallucinogens \u2013 pharmacology, analytical methods, toxicities, fatalities : a review","volume":"19","author":"Kyriakou","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B104","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.drugalcdep.2015.05.048","article-title":"Recreational phenethylamine poisonings reported to a French poison control center","volume":"154","author":"Le Roux","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"B105","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00213-006-0475-3","article-title":"Monitoring extracellular dopamine in the rat nucleus accumbens shell and core during acquisition and maintenance of intravenous WIN 55,212-2 self-administration","volume":"188","author":"Lecca","year":"2006","journal-title":"Psychopharmacology (Berl)."},{"key":"B106","doi-asserted-by":"publisher","first-page":"w14043","DOI":"10.4414\/smw.2015.14043","article-title":"Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling","volume":"145","author":"Liechti","year":"2015","journal-title":"Swiss Med. Wkly."},{"key":"B109","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1476-5381.1965.tb02079.x","article-title":"Central Stimulant Actions of Alpha-Alkyl Substituted Tryptamines in Mice","volume":"24","author":"Lessin","year":"1965","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.neuropharm.2005.03.016","article-title":"Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction","volume":"48","author":"Lupica","year":"2005","journal-title":"Neuropharmacology"},{"key":"B112","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00414-015-1150-1","article-title":"Driving under the influence of synthetic phenethylamines: a case series","volume":"129","author":"Maas","year":"2015","journal-title":"Int. J. Legal Med."},{"key":"B113","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/dar.12225","article-title":"Synthetic cannabinoid withdrawal: a new demand on detoxification services","volume":"34","author":"Macfarlane","year":"2015","journal-title":"Drug Alcohol Rev."},{"key":"B114","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pbb.2014.05.010","article-title":"In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid \u0394(9)-THC in mice: inhalation versus intraperitoneal injection","volume":"124","author":"Marshell","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B115","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0306-4522(98)00052-9","article-title":"Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice","volume":"85","author":"Martellotta","year":"1998","journal-title":"Neuroscience"},{"key":"B116","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/hup.2486","article-title":"Novel psychoactive substances: use and knowledge among adolescents and young adults in urban and rural areas","volume":"30","author":"Martinotti","year":"2015","journal-title":"Hum Psychopharmacol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.neuro.2012.08.003","article-title":"Effects of synthetic cathinones contained in \u201cbath salts\u201d on motor behavior and a functional observational battery in mice","volume":"33","author":"Marusich","year":"2012","journal-title":"Neurotoxicology"},{"key":"B118","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neuropharm.2007.05.028","article-title":"Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area","volume":"54","author":"M\u00e1ty\u00e1s","year":"2008","journal-title":"Neuropharmacology"},{"key":"B119","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.bbr.2010.01.024","article-title":"Chronic WIN55,212-2 elicits sustained and conditioned increases in intracranial self-stimulation thresholds in the rat","volume":"209","author":"Mavrikaki","year":"2010","journal-title":"Behav. Brain Res."},{"key":"B120","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.drugalcdep.2013.09.011","article-title":"Psychoactive substances\u2013some new, some old: a scan of the situation in the U.S","volume":"134","author":"Maxwell","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"B121","doi-asserted-by":"publisher","first-page":"12716","DOI":"10.1523\/JNEUROSCI.1844-14.2014","article-title":"Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in sardinian alcohol-preferring rats","volume":"34","author":"Melis","year":"2014","journal-title":"J. Neurosci."},{"key":"B122","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1742-7843.2006.pto_243.x","article-title":"Rewarding properties of 1-benzylpiperazine, a new drug of abuse, in rats","volume":"98","author":"Meririnne","year":"2006","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/MAJ.0000000000000466","article-title":"Synthetic Cannabinoids","volume":"350","author":"Mills","year":"2015","journal-title":"Am. J. Med. Sci."},{"key":"B124","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s00204-013-1057-x","article-title":"Update on 1-benzylpiperazine (BZP) party pills","volume":"87","author":"Monteiro","year":"2013","journal-title":"Arch. Toxicol."},{"key":"B126","volume-title":"National Drug Treat Assessment","author":"National Drug Intelligence Center (NDIC)","year":"2011"},{"key":"B127","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1124\/pr.112.007419","article-title":"Intracranial self-stimulation to evaluate abuse potential of drugs","volume":"66","author":"Negus","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"B128","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.disamonth.2014.01.001","article-title":"Emerging drugs of abuse","volume":"60","author":"Nelson","year":"2014","journal-title":"Dis. Mon."},{"key":"B129","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","article-title":"Hallucinogens","volume":"101","author":"Nichols","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"B130","author":"NIDA (National Institute on Drug Abuse)","year":"2012","journal-title":"Monitoring the Future 2012 Survey Results"},{"key":"B131","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0304-3940(99)00688-6","article-title":"Ketamine stereoselectively inhibits rat dopamine transporter","volume":"274","author":"Nishimura","year":"1999","journal-title":"Neurosci. Lett."},{"key":"B132","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pnpbp.2016.01.007","article-title":"Effect of JWH-250, JWH-073 and their interaction on \u201ctetrad,\u201d sensorimotor, neurological and neurochemical responses in mice","volume":"15","author":"Ossato","year":"2016","journal-title":"Prog Neuropsychopharmacol. Biol Psychiatry."},{"key":"B133","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/SAR.S37257","article-title":"Emerging drugs of abuse: current perspectives on substituted cathinones","volume":"5","author":"Paillet-Loilier","year":"2014","journal-title":"Subst. Abuse Rehabil."},{"key":"B134","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.08.028","article-title":"Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting","volume":"156","author":"Palamar","year":"2015","journal-title":"Drug Alcohol Depend."},{"issue":"92","key":"B135","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2014.00092","article-title":"Cannabinoid regulation of brain reward processing with an emphasis on the role of CB1 receptors: a step Back into the Future","volume":"5","author":"Panagis","year":"2014","journal-title":"Front. Psychiatry"},{"key":"B136","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/hup.2312","article-title":"\u201cSpiceophrenia\u201d: a systematic overview of \u201cspice\u201d-related psychopathological issues and a case report","volume":"28","author":"Papanti","year":"2013","journal-title":"Hum. Psychopharmacol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.tics.2004.12.008","article-title":"Mapping brain maturation and cognitive development during adolescence","volume":"9","author":"Paus","year":"2005","journal-title":"TrendsCogn Sci."},{"key":"B138","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s13181-011-0193-z","article-title":"The toxicology of bath salts: a review of synthetic cathinones","volume":"8","author":"Prosser","year":"2012","journal-title":"J. Med. Toxicol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/00952990701202970","article-title":"\u201cResearch chemicals\u201d: tryptamine and phenethylamine use among high-risk youth","volume":"43","author":"Sanders","year":"2008","journal-title":"Subst. Use Misuse"},{"key":"B140","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/hup.2410","article-title":"Psyclones: a roller coaster of life? Hidden synthetic cannabinoids and stimulants in apparently harmless products","volume":"30","author":"Santacroce","year":"2015","journal-title":"Hum. Psychopharmacol."},{"key":"B141","first-page":"125","article-title":"Endogenous cannabinoids as an aversive or counter-rewarding system in the rat. Neurosci","volume":"223","author":"Sa\u00f1udo-Pe\u00f1a","year":"1997","journal-title":"Lett."},{"key":"B142","first-page":"259","article-title":"Novel psychoactive substances also known as \u2018legal highs'","author":"Schifano","year":"2013","journal-title":"Annual Report of the Chief MedicalOfficer. Public Mental Health Priorities: Investing in the Evidence"},{"key":"B143","first-page":"110","article-title":"Smokable (\u201cice,\u201d \u201ccrystal meth\u201d) and non smokable amphetamine-type stimulants: Clinical pharmacological and epidemiological issues, with special reference to the UK","volume":"43","author":"Schifano","year":"2007","journal-title":"Ann. Ist Super. Sanita"},{"key":"B144","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000279302","article-title":"Overview ofamphetamine-type stimulant mortality data\u2013UK, 1997-2007","volume":"61","author":"Schifano","year":"2010","journal-title":"Neuropsychobiology"},{"key":"B146","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/wps.20174","article-title":"Novel psychoactive substances of interest for psychiatry","volume":"14","author":"Schifano","year":"2015","journal-title":"World Psychiatry"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-015-4057-0","article-title":"Reinforcing and neurochemical effects of the \u201cbath salts\u201d constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats","author":"Schindler","year":"2015","journal-title":"Psychopharmacology (Berl)."},{"key":"B148","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1124\/mi.11.1.6","article-title":"Marijuana-based drugs: innovative therapeutics or designer drugs of abuse?","volume":"11","author":"Seely","year":"2011","journal-title":"Mol. Interv."},{"key":"B149","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1021\/tx3000472","article-title":"A major glucuronidated metabolite of JWH-018 is a neutral antagonist at CB1 receptors","volume":"39","author":"Seely","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.neuropharm.2011.05.034","article-title":"Endocannabinoid-mediated synaptic plasticity and addiction-related behavior","volume":"61","author":"Sidhpura","year":"2011","journal-title":"Neuropharmacology"},{"key":"B151","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","article-title":"Pharmacological characterization of designer cathinones in vitro","volume":"168","author":"Simmler","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.bcp.2014.01.024","article-title":"Pharmacological profiles of aminoindanes, piperazines, and pipradrol derivatives","volume":"88","author":"Simmler","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/hup.2300","article-title":"Novel psychoactive substances as a novel challenge for health professionals: results from an Italian survey","volume":"28","author":"Simonato","year":"2013","journal-title":"Hum. Psychopharmacol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.1039\/C5AN00797F","article-title":"An overview of recent developments in the analytical detection of new psychoactive substances (NPSs)","volume":"140","author":"Smith","year":"2015","journal-title":"Analyst"},{"key":"B155","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.toxlet.2007.02.007","article-title":"5-Methoxy-N,N-diisopropyltryptamine (Foxy), a selective and high affinity inhibitor of serotonin transporter","volume":"170","author":"Sogawa","year":"2007","journal-title":"Toxicol. Lett."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/nprot.2006.167","article-title":"Using drug-discrimination techniques to study the abuse-related effects of psychoactive drugs in rats","volume":"1","author":"Solinas","year":"2006","journal-title":"Nat Protoc."},{"key":"B157","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00213-013-3188-4","article-title":"Spicing things up: synthetic cannabinoids","volume":"228","author":"Spaderna","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"B158","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1080\/10826080802297302","article-title":"Substance abuse among adolescents","volume":"43","author":"Sussman","year":"2008","journal-title":"Substance Use Misuse"},{"key":"B159","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1126\/science.276.5321.2048","article-title":"Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism","volume":"276","author":"Tanda","year":"1997","journal-title":"Science"},{"key":"B160","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/80577","article-title":"Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys","volume":"3","author":"Tanda","year":"2000","journal-title":"Nat. Neurosci."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijdevneu.2014.12.001","article-title":"The neurotoxicity of amphetamines during the adolescent period","volume":"41","author":"Teixeira-Gomes","year":"2014","journal-title":"Int. J. Dev. Neurosci."},{"key":"B162","first-page":"430","article-title":"Suicidal ideation and self-harm following K2 use","volume":"105","author":"Thomas","year":"2012","journal-title":"J. Okla. State Med. Assoc."},{"key":"B163","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2174\/1570159X13666141210222409","article-title":"Recreational use, analysis and toxicity of tryptamines","volume":"13","author":"Tittarelli","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neuropharm.2015.02.008","article-title":"Novel halogenated derivates of JWH-018: behavioral and binding studies in mice","volume":"95","author":"Vigolo","year":"2015","journal-title":"Neuropharmacology"},{"key":"B165","author":"UNODC","year":"2013","journal-title":"Global Smart Update 2013"},{"key":"B166","author":"UNODC","year":"2014a","journal-title":"Early Warning Advisory on NPS"},{"key":"B167","doi-asserted-by":"crossref","DOI":"10.18356\/bdf42380-en","author":"UNODC","year":"2014b","journal-title":"World Drugs Report"},{"key":"B168","author":"UNODC","year":"2015","journal-title":"The Challenge of Synthetic Drugs in East and South-East Asia and Oceania. Trends and Patterns of Amphetamine-type Stimulants and New Psychoactive Substances"},{"key":"B169","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00204-013-1163-9","article-title":"Khat and synthetic cathinones: a review","volume":"88","author":"Valente","year":"2014","journal-title":"Arch. Toxicol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s002130050013","article-title":"A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice","volume":"147","author":"Valjent","year":"2000","journal-title":"Psychopharmacology"},{"key":"B171","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1177\/0269881114565142","article-title":"The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects","volume":"29","author":"Van Amsterdam","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s00213-004-2050-0","article-title":"CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat","volume":"179","author":"Vlachou","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"B173","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/FBP.0b013e3282186cf2","article-title":"Lack of evidence for appetitive effects of Delta 9-tetrahydrocannabinol in the intracranial self-stimulation and conditioned place preference procedures in rodents","volume":"18","author":"Vlachou","year":"2007","journal-title":"Behav. Pharmacol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1172\/JCI18533","article-title":"The addicted human brain: insights from imaging studies","volume":"111","author":"Volkow","year":"2003","journal-title":"J. Clin. Invest."},{"key":"B175","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1038\/sj.npp.1300481","article-title":"Methamphetamine activates reward circuitry in drug na\u00efve human subjects","volume":"29","author":"V\u00f6llm","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"B176","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0306-4522(03)00020-4","article-title":"Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain","volume":"118","author":"Wang","year":"2003","journal-title":"Neuroscience"},{"issue":"002.","key":"B177","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6105.S9-002","article-title":"The reinforcing and rewarding effects of methylone, a synthetic cathinone commonly found in \u201cBath Salts.\u201d","author":"Watterson","year":"2012","journal-title":"J. Addict. Res. Ther."},{"key":"B178","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1369-1600.2012.00474.x","article-title":"Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV)","volume":"19","author":"Watterson","year":"2014","journal-title":"Addict. Biol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1345\/aph.1P580","article-title":"The \u201cnew\u201d marijuana","volume":"45","author":"Wells","year":"2011","journal-title":"Ann. Pharmacother."},{"key":"B180","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/FTD.0000000000000240","article-title":"New psychoactive substances","volume":"38","author":"Welter-Luedeke","year":"2015","journal-title":"Ther. Drug Monit."},{"key":"B181","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/j.1365-2125.2006.02818.x","article-title":"Speed, Ecstasy, Ritalin: the science of amphetamines","volume":"63","author":"Whelpton","year":"2007","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/jat\/28.1.67","article-title":"A2 (N-benzylpiperazine) a new drug of abuse in Sweden","volume":"28","author":"Wikstr\u00f6m","year":"2004","journal-title":"J. Anal. Toxicol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.drugalcdep.2011.11.001","article-title":"1-Pentyl-3-phenylacetylindoles and JWH-018 share in vivo cannabinoid profiles in mice","volume":"123","author":"Wiley","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"B184","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.lfs.2013.09.011","article-title":"Moving around the molecule: relationship between chemical structure and in vivo activity of synthetic cannabinoids","volume":"97","author":"Wiley","year":"2014","journal-title":"Life Sci."},{"key":"B185","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/hup.2292","article-title":"The 12-month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid products","volume":"28","author":"Winstock","year":"2013","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"B186","first-page":"494","article-title":"Disorders relating to the use of ecstasy, other \u2018party drugs' and khat","author":"Winstock","year":"2009"},{"key":"B188","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3109\/15563650.2014.898771","article-title":"The european drug emergencies network (Euro-DEN)","volume":"52","author":"Wood","year":"2014","journal-title":"Clin. Toxicol. (Phila)."},{"key":"B189","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3109\/15563650.2015.1004179","article-title":"Prevalence of use and acute toxicity associated with the use of NBOMe drugs","volume":"53","author":"Wood","year":"2015","journal-title":"Clin. Toxicol."},{"key":"B190","doi-asserted-by":"publisher","first-page":"e44652","DOI":"10.1371\/journal.pone.0044652","article-title":"Effect of ambient temperature on the thermoregulatory and locomotor stimulant effects of 4-methylmethcathinone in wistar and sprague-dawley rats","volume":"7","author":"Wright","year":"2012","journal-title":"PLoS ONE"},{"key":"B191","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/0306-4522(92)90202-D","article-title":"On the significance of subterritories in the \u201caccumbens\u201d part of the rat ventral striatum","volume":"50","author":"Zahm","year":"1992","journal-title":"Neuroscience"},{"key":"B192","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/bs.irn.2015.02.009","article-title":"\u201cLegal Highs\u201d\u2013An Emerging Epidemic of Novel Psychoactive Substances","volume":"120","author":"Zawilska","year":"2015","journal-title":"Int. Rev. Neurobiol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3238\/arztebl.2009.0464","article-title":"Withdrawal phenomena and dependence syndrome after the consumption of \u201cspice gold.\u201d","volume":"106","author":"Zimmermann","year":"2009","journal-title":"Dtsch. Arztebl. Int."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T20:17:04Z","timestamp":1748895424000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fnins.2016.00153\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,19]]},"references-count":179,"URL":"https:\/\/doi.org\/10.3389\/fnins.2016.00153","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,19]]}}}